Ensifentrine is billed as a first-in-class dual inhibitor of the enzymes phosphodiesterase 3 and 4 (PDE3 and PDE4), and is thought to combine bronchodilator ... be on the hit-list of potential ...

Failure to respond to initial bronchodilators ... so this decision should be patient condition [4,5]. A long list of adverse reactions, including GI, skin, neurological, musculoskeletal and ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

A novel, fixed-duration drug combination—consisting of a second-generation BTK inhibitor, called acalabrutinib, plus a BCL-2 ...

The Prescrire journal has published its assessment of drugs to avoid in 2025, highlighting 106 drugs with an unfavourable ...

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala (mepolizumab) in chronic obstructive pulmonary disease (COPD) treatment for ...

Constrictive bronchiolitis obliterans is an important respiratory illness because of its underlying irreversible fibrotic process, and is defined as concentric fibrosis in the bronchiolar ...

Nitric oxide is endogenously released in the airways by nitric oxide synthase. Functionally, two isoforms of this enzyme exist: constitutive and inducible. The former seems to protect airways from ...

This can prevent damage to their brains and other body organs from lack of oxygen. They also are given surfactant and medicines, including bronchodilators to improve the flow of air in and out of the ...

List your movie, TV & celebrity picks. Your list will be visible to everyone.